Measurement of the biomarker copeptin in the ambulance may allow medics to quickly rule out myocardial infarction in patients with chest pain, randomized results of the AROMI trial suggest.
The natural experiment of COVID-19 lockdown suggests that reducing ambient air pollution can reduce risk for the most severe type of MI, researchers say.
The clinical practice guideline offers a contemporary approach to determine which patients need further testing and which do not, and discourages the use of atypical in favor of noncardiac chest pain.
The American Heart Association has issued a new policy statement that includes a host of recommendations to further overcome barriers to optimal care for ST-segment elevation MI, the most severe type.